We are live on ! Find out more
SS

SBI Securities Portfolio holdings

AUM $4.4B
1-Year Est. Return 74.26%
This Fund
S&P 500
This Quarter Est. Return
+3.22%
1 Year Est. Return
+74.26%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.89B
AUM Growth
-$15.1M
Cap. Flow
-$69.6M
Cap. Flow %
-1.79%
Top 10 Hldgs %
43.27%
Holding
4,279
New
94
Increased
1,155
Reduced
1,883
Closed
250

Top Sells

Rank Stock Value
1
ATEX icon
Anterix
ATEX
+$37.7M
2
TSLA icon
Tesla
TSLA
+$24.7M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$15.6M
4
NVDA icon
NVIDIA
NVDA
+$9.57M
5
PLTR icon
Palantir
PLTR
+$7.17M

Sector Composition

Rank Sector Weight
1 Miscellaneous 42.42%
2 Technology 28.51%
3 Communication Services 7.22%
4 Consumer Discretionary 6.74%
5 Financials 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QNCX icon
3126
Quince Therapeutics
QNCX
$34.3M
0
GROW icon
3127
US Global Investors
GROW
$41.3M
$260 ﹤0.01%
108
SHCO
3128
DELISTED
Soho House & Co
SHCO
$260 ﹤0.01%
29
PCRX icon
3129
Pacira BioSciences
PCRX
$1.03B
$259 ﹤0.01%
10
-2
-17% -$48
AX icon
3130
Axos Financial
AX
$5.55B
$258 ﹤0.01%
3
-12
-80% -$988
PRI icon
3131
Primerica
PRI
$8.94B
$258 ﹤0.01%
1
AIT icon
3132
Applied Industrial Technologies
AIT
$11.8B
$257 ﹤0.01%
1
CPSH icon
3133
CPS Technologies
CPSH
$73.7M
$256 ﹤0.01%
83
GDOT icon
3134
Green Dot
GDOT
$760M
$256 ﹤0.01%
20
-35
-64% -$435
ADIL
3135
Adial Pharmaceuticals
ADIL
$16.4M
$255 ﹤0.01%
46
-10
-18% -$81
GHRS icon
3136
GH Research
GHRS
$1.92B
$254 ﹤0.01%
+20
New +$272
ENGN icon
3137
enGene Therapeutics
ENGN
$122M
$253 ﹤0.01%
28
-3
-10% -$24
CLBT icon
3138
Cellebrite
CLBT
$3.01B
$252 ﹤0.01%
14
-130
-90% -$2.33K
PRSO icon
3139
Peraso
PRSO
$9.68M
$251 ﹤0.01%
288
-100
-26% -$118
ASO icon
3140
Academy Sports + Outdoors
ASO
$2.7B
$250 ﹤0.01%
5
BDTX icon
3141
Black Diamond Therapeutics
BDTX
$128M
$250 ﹤0.01%
103
-4
-4% -$14
AGL icon
3142
Agilon Health
AGL
$1.55B
$249 ﹤0.01%
14
-9
-39% -$175
VRA icon
3143
Vera Bradley
VRA
$94.1M
$249 ﹤0.01%
103
CCC
3144
CCC Intelligent Solutions
CCC
$4.41B
$246 ﹤0.01%
31
-6
-16% -$49
COO icon
3145
Cooper Companies
COO
$13.9B
$246 ﹤0.01%
3
-2
-40% -$150
LYRA
3146
DELISTED
LYRA THERAPEUTICS INC
LYRA
$246 ﹤0.01%
80
RDZN icon
3147
Roadzen
RDZN
$126M
$246 ﹤0.01%
102
-2
-2% -$3
EB
3148
DELISTED
Eventbrite
EB
$245 ﹤0.01%
55
TDUP icon
3149
ThredUp
TDUP
$357M
$243 ﹤0.01%
38
+33
+660% +$267
ALGS icon
3150
Aligos Therapeutics
ALGS
$43.1M
$242 ﹤0.01%
26

Similar funds

SBI Securities's Q4 2025 Portfolio in Review

As of Q4 2025, SBI Securities held 4,279 positions worth $3.89B, down 0.39% from $3.9B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

SBI Securities's Q4 2025 filing shows 94 new, 1,155 increased, 1,883 reduced and 250 closed positions. Its largest new stake was Berkshire Hathaway Class B: 74,213 shares worth $37.3M. The largest sale was Anterix, an estimated $37.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 42% a quarter earlier, followed by Technology and Communication Services.

  • SBI Securities's largest Q4 2025 buy was Berkshire Hathaway Class B: 74,213 shares worth $37.3M.
  • SBI Securities added most to Celsius Holdings in Q4 2025, an estimated $5.86M increase.
  • SBI Securities's biggest Q4 2025 reduction was Tesla, cutting an estimated $24.7M.
  • SBI Securities fully exited Anterix in Q4 2025, selling an estimated $37.7M.
  • SBI Securities's ten largest holdings make up 43% of its $3.89B portfolio in Q4 2025.
  • SBI Securities opened 94 new positions and closed 250 in Q4 2025.
  • SBI Securities's portfolio value fell 0.39% quarter-over-quarter to $3.89B.

Based on SBI Securities's 13F filing for Q4 2025, filed 3 Feb 2026.